Years Experienced
Research
Partners
All our efforts are focused on developing a therapy able to substitute chronic palliative treatment with definitive healing. Through our nanotechnology, we inform the immune system about a mistake in order to interrupt attacks on self-tissues, thereby generating tolerance against a specific auto-antigen but keeping systemic immunity active.
Our approach, based on Nano-technology, has allowed us to develop a powerful and highly specific pharmacological platform designed to treat and cure Autoimmune diseases.
Myasthenia Gravis, Type 1 Diabetes, Multiple Sclerosis, Celiac Disease, Rheumatoid Arthritis, Neuromyelitis Optica, Immune Thrombotic Thrombocytopenic Purpura, and more.
Our strategic alliances help accelerate innovation and expand patient impact. We are always open to exploring new opportunities that align with with our mission to restore immune balance and improve quality of live.
CEO
CTO – CMC Director
Ahead Therapeutics is a biotechnology company with a team of experienced professionals who are dedicated to developing groundbreaking therapies for autoimmune and inflammatory diseases. Led by CEO Marti Dalmases, the team includes experts in immunology, drug development, and business management. They are committed to bringing life-changing treatments to patients in need.
BARCELONA, Jan. 29, 2026 — Ahead Therapeutics, a Spanish biotechnology company focused on transformative solutions
Barcelona, 14 August 2025 – Ahead Therapeutics S.L is proud to announce that we will
Ahead Therapeutics, a biotech company developing a platform technology to induce antigen-specific immune tolerance for
